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Genome-wide analysis suggests 
a differential microRNA signature 
associated with normal and 
diabetic human corneal limbus
Mangesh Kulkarni1,2, Aleksandra Leszczynska1,2, Gabbie Wei1,2, Michael A. Winkler1,2, 
Jie Tang  3, Vincent A. Funari3, Nan Deng4, Zhenqiu Liu4, Vasu Punj5, Sophie X. Deng6, 
Alexander V. Ljubimov1,2,6 & Mehrnoosh Saghizadeh1,2,6
Small non-coding RNAs, in particular microRNAs (miRNAs), regulate fine-tuning of gene expression 
and can impact a wide range of biological processes. However, their roles in normal and diseased 
limbal epithelial stem cells (LESC) remain unknown. Using deep sequencing analysis, we investigated 
miRNA expression profiles in central and limbal regions of normal and diabetic human corneas. We 
identified differentially expressed miRNAs in limbus vs. central cornea in normal and diabetic (DM) 
corneas including both type 1 (T1DM/IDDM) and type 2 (T2DM/NIDDM) diabetes. Some miRNAs such 
as miR-10b that was upregulated in limbus vs. central cornea and in diabetic vs. normal limbus also 
showed significant increase in T1DM vs. T2DM limbus. Overexpression of miR-10b increased Ki-67 
staining in human organ-cultured corneas and proliferation rate in cultured corneal epithelial cells. 
MiR-10b transfected human organ-cultured corneas showed downregulation of PAX6 and DKK1 
and upregulation of keratin 17 protein expression levels. In summary, we report for the first time 
differential miRNA signatures of T1DM and T2DM corneal limbus harboring LESC and show that miR-
10b could be involved in the LESC maintenance and/or their early differentiation. Furthermore, miR-10b 
upregulation may be an important mechanism of corneal diabetic alterations especially in the T1DM 
patients.
Many forms of corneal conditions can be sight threatening, such as diabetic keratopathy and limbal stem cell 
deficiency (LSCD) that is hard to treat even with corneal transplantation. Such diseases are related to abnormal 
self-renewal and wound healing due to epithelial dysfunction. Corneal epithelium is constantly renewed by lim-
bal epithelial stem cells (LESC) that in humans exclusively reside in the corneoscleral junction, limbus1–3. LESC 
have lifetime capacity for self-renewal, and the ability to generate transient amplifying (TA) cells, which in turn 
differentiate into central corneal epithelium. Epithelial cells must remain in homeostasis to ensure normal epi-
thelial function. This includes maintenance, self-renewal and differentiation, which are important parts of the life 
cycle of corneal epithelium.
In recent years, there has been growing understanding of the dynamic role played by microRNAs (miRNAs) 
in modulating tissue homeostasis. MiRNAs are evolutionarily conserved small noncoding RNAs that regulate 
gene expression post-transcriptionally by binding to complementary sequences on 3′UTR of target mRNA that 
usually results in gene silencing by inducing mRNA degradation or inhibition of mRNA translation4–7. MiRNAs 
have a unique multi-targeted mode of action enabling each miRNA to regulate the expression of multiple genes 
in contrast to traditional inhibitors that target one specific protein6, 7. Many recent studies have shown the sig-
nificant role of miRNA in development and maintenance of stem cells, and function during differentiation8, 9. 
Whereas others and we have documented the role of miRNAs in wound healing, tissue maintenance and 
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differentiation10–17, few studies have explored the role of miRNAs in LESC homeostasis and corneal diseases14, 
17–21. Stem or progenitor cells embrace great potential in regenerative medicine for treatment of corneal diseases. 
Therefore, the mechanistic study of LESC miRNAs could provide us with new insights into the regulatory mech-
anisms of stem cells in normal and pathological states.
Previously, we reported miRNA expression profiling in the central part of normal and diabetic corneas using 
microarray analysis12. In the present study deep sequencing, which is a more sensitive and quantitative method 
with broader dynamic range22, has been employed to determine the miRNA expression profiles in human 
limbal compartment and central cornea in normal, as well as in insulin dependent diabetes mellitus (IDDM/
T1DM) and non-insulin dependent diabetes mellitus (NIDDM/T2DM). We aimed at identifying differentially 
expressed miRNAs in human limbal epithelial cells (LEC) vs. mature central epithelium in normal and diabetic 
corneas, as well as detecting miRNAs dysregulated in diabetes. We also examined how certain limbal-enriched 
and diabetes-increased miRNAs function in regulatory pathways involved in corneal epithelial self-renewal and 
differentiation in normal and disease states.
To our knowledge, this is the first study using genome-wide microRNA expression profiling in normal vs. 
T1DM and T2DM limbal and central human corneas by high throughput sequencing. We also provide novel 
data on the role of miR-10b, one of the most abundant limbal miRNAs, in the corneal epithelium with possible 
function in LEC homeostasis.
Results
Deep sequencing revealed miRNA expression profiles of normal and diabetic corneas. Library 
integrity and mapping. Library integrity was determined by mapping all reads between 20–30 nt to human 
genome. MiRNAs were identified and quantified by simultaneously mapping reads to human genome and 
Figure 1. Differentially expressed limbus vs. central miRNAs in normal and diabetic corneas. (a–d) PCA and 
two-way hierarchical clustering plots of limbus vs. central cornea. (a,b) 34 differentially expressed miRNAs in 
normal limbus vs. central cornea. (c,d) 36 differentially expressed miRNAs in diabetic limbus vs. central cornea. 
t-test, FDR adjusted p < 0.05. (e) Venn diagrams of up-regulated (left) and down-regulated miRNAs (right) in 
two-group comparisons of differentially expressed miRNAs (adjusted p < 0.05) in normal and diabetic limbus 
vs. central corneas. (f) Venn diagram of differentially expressed limbus vs. central miRNAs in three-group 
comparisons in normal, T1DM (IDDM) and T2DM (NIDDM).
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miRBase. Unmapped sequences were neither repetitive nor represented unknown transcripts, nor were present 
due to contamination as they rarely mapped against RepBase23, NCBI UniGen cluster or non-human genomes. 
On an average >75% of ncRNA was found to be microRNAs.
Differentially expressed miRNAs in limbus vs. central in normal and diabetic corneas. After filtering miRNAs as 
detailed in Materials and Methods, a total of 192 miRNAs were analyzed for further differential expression in a 
two-group analysis. A set of 47 miRNAs (Supplementary Table S1) was identified as differentially expressed in 
normal limbus vs. central cornea with a raw p < 0.05 and fold change of ±1.4. Of these 47 miRNAs 34 miRNAs 
showed a false discovery rate (FDR)-adjusted p ≤ 0.05. A principal component analysis (PCA) and hierarchical 
clustering showed a clear distinction between normal limbus vs. central cornea (Fig. 1a and b). Similarly, a set 
of 36 miRNAs with FDR-adjusted p ≤ 0.05 showed a distinct grouping into diabetic limbus vs. central cornea 
(Fig. 1c and d, and Supplementary Table S2). There were 35 miRNAs upregulated and just one miRNA downreg-
ulated in diabetic limbus vs. central cornea (Fig. 1d and Supplementary Table S2). Of 34 differentially expressed 
miRNAs in normal limbus vs. central cornea (FDR p ≤ 0.05), 27 and 7 miRNAs were upregulated or downregu-
lated, respectively (Fig. 1b and Supplementary Table S1). Venn diagram comparison of differentially expressed 
limbal vs. central miRNAs in normal and DM corneas revealed 24 common upregulated and one downregulated 
miRNAs, whereas 11 and three upregulated miRNAs were unique to DM and normal samples, respectively, and 
six downregulated expressed miRNAs unique to normal samples (Fig. 1e).
PCA and two-way hierarchical clustering of diabetic vs. normal limbal samples revealed 20 differentially 
expressed miRNAs (Supplementary Table S3), 13 upregulated and seven downregulated in DM vs. normal lim-
bus, (p < 0.05; ±1.3 fold change). Both diabetic groups, T1DM and T2DM, additionally showed distinct differen-
tial expression patterns of limbus vs. central cornea. Comparison of normal and T1DM or T2DM diabetic groups 
revealed that normal samples shared less differentially expressed limbus vs. central miRNAs with T2DM than 
with T1DM samples, 4 vs. 18 miRNAs (Fig. 1f), suggesting that miRNA expression profiles of T1DM and T2DM 
groups may be differentially clustered and separated from each other.
Differentially expressed miRNAs in T1DM vs. T2DM corneal limbus. Interestingly, PCA and hierarchical clus-
tering showed that the miRNA expression profiles of T1DM and T2DM limbal groups were separated from each 
other (Fig. 2a and b). Seven miRNAs were upregulated whereas 12 miRNAs were downregulated (1.4-fold cutoff; 
adjusted p < 0.05) in T1DM vs. T2DM limbus (Supplementary Table S4). Some miRNAs such as miR-10b that 
was upregulated in limbus vs. central cornea and upregulated in diabetic limbus also showed significant increase 
in T1DM vs. T2DM limbus. A representative genomic view of the aligned reads for miR-10b in IGV (Integrated 
genomic viewer) suggests robust increase in the expression of miR10b in normal limbus vs. central as well as in 
diabetic vs. normal limbus (Fig. 2c) supporting the bioinformatics approach detailed here.
Figure 2. Differentially expressed limbal miRNAs in T1DM vs. T2DM. (a) PCA, and (b) hierarchical clustering 
of 19 differentially expressed gene in T1DM (IDDM) vs. T2DM (NIDDM) in limbus, FDR adjusted p < 0.05;  
(c) Genomic snapshot of miR-10b in representative two samples from each two-group comparisons.
www.nature.com/scientificreports/
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Validation of differentially expressed miRNAs using QRT-PCR and in situ hybridization. The 
performance of our deep sequencing and bioinformatics approach was validated using quantitative RT-PCR 
(QRT-PCR). Selected miRNAs differentially expressed in both normal and diabetic limbus vs. central cornea 
and in diabetic vs. normal limbus were validated by QRT-PCR in independent samples (Supplementary Fig. S1 
and Figs 3 and 4). There was a strong concordance between QRT-PCR and deep sequencing data analysis of 
differentially expressed miRNAs in limbus vs. central in both normal (correlation r = 0.93; Fig. 3a) and diabetic 
(correlation r = 0.90; Fig. 3b) samples. miR-10b, miR-126, miR-127-3p, miR-186, miR-146a, and miR-21 were 
elevated in both normal and diabetic limbus vs. central (Supplementary Figs S1a,b and 3a,b), whereas miR-486 
was down regulated just in the normal and miR-25-3p was down regulated just in the diabetic limbus vs. central 
cornea in accordance with deep sequencing data (Fig. 3a and b). In situ hybridization with locked nucleic acid 
(LNA) modified probes, which was performed on sections of normal corneas to localize miRNA expression, fur-
ther corroborated our sequencing data (Fig. 3c). It showed that the signals for miR-146a, miR-126 and miR-10b 
were stronger in the limbus than in the central cornea (Fig. 3c).
Further, there was a concordance between QRT-PCR and deep sequencing data in differentially expressed 
miRNAs in diabetic vs. normal limbal samples (correlation r = 0.78) (Supplementary Fig. S1c and Fig. 4a). 
Differential expression of miR-10b in T1DM vs. T2DM was validated by both QRT-PCR (Fig. 4b) and in situ 
hybridization (Fig. 4c). It was more pronounced in T2DM than in normal limbus and was upregulated signifi-
cantly in T1DM vs. both T2DM and normal limbi. Further, miR-10b was more expressed in the LESC-harboring 
basal cell layer in normal limbal epithelium (Fig. 4c) suggesting its roles in stem cell maintenance or early prolif-
eration/differentiation in normal corneal homeostasis. U75 and U6 miRNAs were used as internal and positive 
controls in QRT-PCR and in situ hybridization, respectively, and scrambled sequences were used as negative 
controls (Figs 3 and 4).
miR-10b predicted targets and Gene Ontology analysis. Due to significant differential enrichment 
of miR-10b in the limbus and in diabetic cornea, we further investigated its potential biological function by 
Figure 3. Validation of deep sequencing data of differentially expressed limbus vs. central corneal miRNAs. 
(a,b) Quantitative RT-PCR validation of deep sequencing data, limbus vs. central cornea. Several miRNAs are 
differentially expressed in limbus vs. central cornea. There was a strong concordance between QRT-PCR and 
deep sequencing data on differentially expressed limbal vs. central miRNAs in normal ((a) correlation r = 0.93) 
and diabetic ((b) correlation r = 0.90) samples, Each sample was run in triplicate. (c) In situ hybridization with 
locked nucleic acid (LNA) modified probes, miR-146a, miR-126 and miR-10b, was performed on sections of 
normal corneas, compared to scrambled sequences. The miRNA signals are stronger in the limbus than in the 
central cornea and more expressed in the basal cell layer in limbal epithelium (arrows). U6 miRNA probe and 
scrambled sequences were used as positive and negative controls, respectively. Bar = 60 μm.
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computational analysis using miRTarBase, the experimentally validated miRNA-target interactions database, 
to find predicted targets for miR-10b. 294 predicted target genes of miR-10b-5p were extracted from miRTar-
Base. The predicted target gene list was used to perform the gene ontology (GO) enrichment analysis using 
DAVID Functional Annotation Bioinformatics Resources v6.8. The significantly enriched GO terms of biolog-
ical process are shown in Supplementary Table S5. The potential target genes are only presented by selecting 
epithelium-related genes and the experimentally validated targets. HOXD10 gene was among the high predicted 
and experimentally observed miR-10b targets. Interestingly, most of the significant GO enrichments for validated 
and/or epithelial-related genes were related to regulation of transcription, differentiation, apoptosis, cell cycle and 
proliferation. It seems that miR-10b target genes are mostly involved in transcription regulation and signal trans-
duction, such as Ras and canonical Wnt signaling pathways, which are both involved in a wide range of cellular 
processes including gene expression, proliferation, differentiation, and apoptosis.
Functional analysis of miR-10b in corneal epithelial homeostasis. By deep sequencing, miR-10b 
was one of the most abundant miRNA in the limbus and had the greatest fold difference in limbus vs. central 
cornea (91.844 fold, Adjusted p < 1.18E-07). By in situ hybridization it was more pronounced in the basal and 
suprabasal epithelial cell layers (Fig. 4c).
miR-10b enhances cell proliferation in human organ-cultured cornea and in cultured cells in vitro. First, we 
verified the increased miR-10b expression levels by QRT-PCR in human organ-cultured cornea, cultured 
telomerase-immortalized human corneal epithelial cells (HCEC) and primary LEC transfected with miR-10b 
mimic (M) or its inhibitor in comparison to their corresponding controls (Supplementary Fig. S2a–c). Although 
present in corneas and HCEC, in primary LEC miR-10 was only detected in isolated cells (passage P0), but not in 
Figure 4. Validation of deep sequencing data of differentially expressed miRNAs in diabetic vs. normal 
limbus. (a) QRT-PCR validation of deep sequencing data, diabetic vs. normal limbus. Several miRNAs are 
indeed differentially expressed in diabetic vs. normal limbus. The results are in good agreement with deep 
sequencing analysis (correlation r = 0.78). (b) QRT-PCR validation of deep sequencing shows that miR-10b 
is expressed significantly more in T1DM (IDDM) than in T2DM limbus and more in T2DM (NIDDM) than 
in normal limbus. (c) miR-10b, in situ hybridization with LNA modified probes was performed on sections 
of normal and both T1DM (IDDM) and T2DM (NIDDM) corneas, compared to scrambled sequences. The 
miRNA signals are stronger in the T1DM than in T2DM limbus and the signals are stronger in T2DM than 
normal limbus, corroborating our QRT-PCR and deep sequencing data. U6 miRNA probe and scrambled 
sequences were used as positive and negative controls, respectively. Bar = 60 μm.
www.nature.com/scientificreports/
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cells at later passages such as in P1, P2 and P3 (Supplementary Fig. S2d). Human organ-cultured corneas trans-
fected with miR-10b showed increased Ki-67 immunostaining in the epithelial basal cell layer in comparison 
to the transfected corneas with mimic control or miR-10b inhibitor (Fig. 5a). Further, we assessed the effects of 
miR-10b overexpression or inhibition on cultured HCEC proliferation rate using MTS cell proliferation assay. 
Overexpression of miR-10b or its inhibition in cultured HCEC showed increase or decrease in cell proliferation, 
respectively (Fig. 5b). We also examined the effect of miR-10b on cell migration in HCEC by gain- and loss- of 
function analyses. Overexpression of miR-10b or its inhibition in HCEC had no significant effect on cell migra-
tion rates compared to controls as determined by a scratch wound healing assay.
mRNA profiling using Fluidigm QRT-PCR reveals potential targets of miR-10b in HCEC. We performed the 
mRNA profiling of HCEC with both miR-10b up regulation and down regulation by Fluidigm QRT-PCR using a 
panel of primers specific to putative stem cell markers and miR-10b predicted targets (Supplementary Table S6). 
Overexpression of miR-10b in cultured HCEC decreased, whereas its inhibition significantly increased mRNA 
expression levels of predicted miR-10b target genes HBEGF, EDEM1, TP53, and PTEN (Fig. 6a,b) and putative 
LESC marker genes, CDH2 and SOX9, compared to their corresponding controls. However, two other LESC/lim-
bal epithelial marker genes, KRT15 and KRT17, and pluripotent stem cell marker gene, OCT4, showed significant 
increase with miR-10b overexpression and significant decrease with miR-10b inhibition in HCEC (Fig. 6a,b). 
LESC marker genes ∆NP63, KRT14 and differentiated epithelial cell marker genes KRT12 and KRT3 did not 
show any significant changes in their mRNA expression level in transfected HCEC. Interestingly, mRNA expres-
sion levels of Dickkopf Wnt signaling pathway inhibitor 1 (DKK1) and glycogen synthase kinase-3β (GSK-3β), 
which is also a Wnt signaling inhibitor, decreased upon miR-10b overexpression, whereas a significant increase in 
miR-10b inhibitor-transfected HCEC (Fig. 6a,b) was observed. These data suggested a possible activation of Wnt 
signaling in miR-10b-transfected HCEC.
miR-10b regulates K17 in HCEC culture and in human organ-cultured corneas. Overexpression of miR-10b in 
cultured HCEC increased the expression of keratin 17 (K17) at the protein level, and the inhibitor had an opposite 
effect (Fig. 7a). Additionally, immunostaining of organ-cultured corneas treated with miR-10b mimic showed a 
similar increase in K17 compared to the fellow corneas transfected with scrambled sequences, mimic control, or 
miR-10b inhibitor (Fig. 7b). Further, miR-10b treatment of HCEC led to modest increase in K17 expression vs. 
scrambled mimic control, whereas silencing of miR-10b using its inhibitor led to decreased K17 expression by 
western blot (Fig. 7c,d).
Verification of miR-10b predicted targets in cultured HCEC and human organ-cultured corneas. In silico anal-
ysis of miR-10b predicted targets using several target prediction software programs along with our mRNA 
Figure 5. Effect of miR-10b on proliferation in normal human organ-cultured corneas and HCEC. (a) miR-
10b treatment in human organ-cultured corneas led to increased expression of Ki-67 in mimic-treated cornea 
compared to the fellow cornea treated with scrambled control, mimic control, or miR-10b inhibitor. (b) MTS 
proliferation assay showed significant increase or decrease in proliferation rates in HCEC transfected with 
miR-10b (M), or miR-10b inhibitor (I), respectively, in comparison to their respective transfected scrambled 
controls, mimic control (MC) and inhibitor control (IC). *P < 0.05, compared with scrambled control values by 
paired two-tailed t test.
www.nature.com/scientificreports/
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profiling revealed potential target proteins that are known to regulate corneal epithelial homeostasis (Table S5 
and Fig. 6), such as PAX6, KLF4, and DKK1. Immunostaining for two potential targets, PAX6 and KLF4, in 
miR-10b transfected organ-cultured corneas revealed significant down-regulation of PAX6 vs. mimic control or 
inhibitor-transfected organ-cultured corneas; while, KLF4 expression had a tendency toward down regulation 
that did not reach significance (Fig. 8a,b). However, in cultured HCECs, changes observed in KLF4 or PAX6 
expression level upon miR-10b overexpression or inhibition were non-significant. Interestingly, DKK1 (Wnt sig-
naling inhibitor) expression level decreased upon miR-10b overexpression both in organ-cultured corneas by 
immunostaining and in cultured cells by western blot, with an opposite effect observed upon miR-10b inhibition 
(Fig. 8a–c). The difference was statistically significant after 6 days of treatment.
Discussion
The present study revealed differential expression of specific miRNAs in anatomically and functionally distinct 
corneal compartments in both healthy and diabetic corneas. Interestingly, in the limbus, which is more metabol-
ically active than central cornea, most miRNAs had much higher expressions suggesting their possible roles in 
LESC maintenance and differentiation both in normal and diseased tissue. Using deep sequencing with QRT-PCR 
validation, we have identified a number of differentially expressed miRNAs in limbus vs. central cornea, some 
of which have not been documented previously (Table S1). In fact, miRNA expression profile of human dia-
betic corneas has been studied here for the first time using deep sequencing. Although there are some common 
overexpressed or underexpressed limbal vs. central miRNAs in normal and diabetic corneas, there are some 
unique differences in the diabetic limbus (Fig. 1e) suggesting altered expression contributing to the disease state. 
Furthermore, we assessed for the first time the miRNAs that are differentially expressed in human diabetic vs. 
normal limbus, which were also validated by QRT-PCR. The difference in T1DM and T2DM miRNA expression 
profiles in the limbal cornea was a striking and novel observation as confirmed by several analyses (Figs 1f and 
2a,b).
The miRNA expression profiles in normal human cornea revealed miR-10b as one of the most abundant miR-
NAs in the limbus. Moreover, as documented by in situ hybridization and a previous study24, miR-10b expression 
Figure 6. miRNA Profiling of miR-10b Transfected HCEC by Fluidigm QPCR. Transfection with miR-10b 
mimic using RNAiMax decreased significantly the mRNA expression level of some putative LESC markers and 
miR-10b predicted targets (a). Transfection with miR-10b inhibitor significantly increased their expression 
levels (b) in HCEC compared to their corresponding scrambled sequence controls (mimic control and inhibitor 
control, respectively). Further, the putative LESC marker mRNA levels that were increased in HCEC transfected 
with miR-10b, showed decreased levels in HCEC transfected with miR-10b inhibitor in comparison to 
corresponding controls. Student’s t-test P < 0.05.
www.nature.com/scientificreports/
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was more pronounced in the basal cell layers. This finding suggests its possible role in stem cell maintenance 
or early TA cell differentiation. Additionally, we confirmed its upregulation in diabetic vs. normal limbus with 
higher expression in T1DM vs. T2DM, where it was expressed in basal, suprabasal, and superficial epithelial lay-
ers suggesting that its different spatial expression compared to normal limbus may contribute to diabetic corneal 
disease. Interestingly, miR-10b expression, which was identified in immortalized cultured HCEC, ex-vivo and 
organ-cultured corneas, was only detected in isolated primary LEC at P0, but not in subsequent culture cells at 
later passages24 (Supplementary Fig. S2d). This suggests that miR-10b is involved in normal LEC maintenance 
in vivo and calls for careful interpretation of cell culture data. miR-10b has been shown to be an important cell 
regulator of a wide variety of cell functions, and can target different genes in different cell types. miR-10b is asso-
ciated with tumor growth and can modulate the epithelial-mesenchymal transition (EMT), which is a critical 
step toward pluripotency25–27. Its possible target in neural cell differentiation is NCOR228, as well as major tran-
scription factors controlling eye development, PAX6, Krüppel-like factor 4 (KLF4) and Notch-126, 27. Although 
considerable studies have been done on the biological functions and downstream targets of miR-10b in cancer 
cells, much is still to be revealed on its physiological roles in normal cells. miR-10b can act upon PAX6 and KLF4 
that are transcription factors playing important roles in the development and maintenance of the cornea. KLF4 
regulates cell cycle and is elevated in terminally differentiated epithelial cells29–31. Therefore, downregulation trend 
Figure 7. Effect of miR-10b on LEC marker K17 expression in HCEC and in normal human organ-cultured 
corneas by immunostaining and western blot. (a) Transfection with miR-10b increased, whereas with miR-
10b inhibitor decreased staining for K17 in HCEC compared to their corresponding controls. (b) MiR-10b 
treatment in human organ-cultured corneas led to increased expression of K17 compared to scrambled mimic 
control or Inhibitor. The same exposure time was used for each set of compared immunostained sections, 
and the assessment was done by more than one observer. The pictures are representative of two to three 
independent experiments. (c) Western blot analysis, total extracted protein from transfected HCEC with miR-
10b mimic (M) or its inhibitor (I) and their corresponding controls, mimic control (MC) and inhibitor control 
(IC), respectively, was separated on gradient SDS-PAGE gels, transferred to membrane and probed with K17 
antibody (Table 2). Antibody to β-actin was used as loading controls and for semi-quantitation. miR-10b 
treatment decreased, whereas its inhibitor increased, protein level of K17. (d) Quantitation of K17 protein level. 
The bar graph represents average ± SEM of pooled values (n = 4) of densitometric scans. *P < 0.05, compared 
with scrambled control values by paired two-tailed t test.
www.nature.com/scientificreports/
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of KLF4 in miR-10b transfected human organ-cultured corneas may suggest the role of miR-10b in early prolifer-
ation/differentiation of LESC. Increased epithelial proliferation with downregulation of desmosomal components 
leading to epithelial fragility in the corneas of KLF4 null mice30 is consistent with diabetic corneal alterations32, 33.
PAX6 has a major role in corneal epithelial homeostasis, differentiation and wound healing34–37. In addition, 
EGF-induced proliferation leads to down-regulation of PAX6 expression for corneal epithelial proliferation38. 
A central role of the Wnt7A–PAX6 axis in corneal epithelial cell fate determination and differentiation has been 
Figure 8. Effect of miR-10b on its predicted targets in human organ-cultured corneas and in HCEC.  
(a) Transfection with miR-10b (10bM) showed decreased, whereas with miR-10b inhibitor (10bI) increased 
staining for PAX6, KLF4 and DKK1 in human organ-cultured corneas (n = 4). The same exposure time 
was used for each set of compared immunostained sections, the pictures are representative of two to three 
independent experiments of each transfected organ-cultured corneas (n = 4). (b) The staining assessment was 
done by more than one observer. The bar graph represents average ± SEM of pooled values (n = 4) in duplicates 
or triplicates. (c) Western blot analysis of total extracted protein from transfected HCEC with miR-10b mimic 
(M) or its inhibitor (I) and their corresponding controls, mimic control (MC) and inhibitor control (IC), 
respectively, after day 3 (D3) or day 6 (D6), and (d) Quantitation of DKK1 protein level in western blot. The 
bar graph represents average ± SEM of pooled values (n = 4) of densitometric scans. *P < 0.05, compared with 
scrambled control values by paired two-tailed t test.
www.nature.com/scientificreports/
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recently suggested39. Interestingly, our mRNA profiling showed down-regulation of Wnt7A in HCEC with over-
expressed miR-10b, and its up regulation upon miR-10b inhibition. The observed trend toward down regulation 
of both Wnt7A and PAX6 in HCEC with overexpressed miR-10b may suggest a possible role of miR-10b in LESC 
proliferation and/or their differentiation to TA cells. PAX6 mutation is common in abnormal eye development 
leading to aniridia, glucose intolerance and development of diabetes40, 41. PAX6 impaired function or its condi-
tional inactivation causes early onset of diabetes and corneal opacification42, 43. Therefore, altered spatial over-
expression of miR-10b in diabetic limbus and downregulation of PAX6 in suprabasal and superficial layers may 
contribute to diabetic corneal alterations44.
Keratins have been used as marker proteins at distinct stages during cellular epithelial differentia-
tion45–47. K15 is expressed in all types of developing stratified epithelia and is considered as one of the earli-
est stratification-related keratins48. Both K15 and K17 are considered as putative stem cell markers due to their 
expression in the basal cell layer of normal squamous stratified epithelia49, 50; they may also be expressed in TA 
cells. Additionally, K15 has been shown as a marker of laterally differentiating epidermal keratinocytes in the 
basal layer51. Therefore, significant upregulation of K15 and K17 mRNA levels in miR-10b transfected HCEC 
may suggest a regulatory role of miR-10b in early and lateral differentiation of LESC to TA cells. New roles of 
keratins have emerged beside their intracellular structural and mechanical functions52–54. These include the role 
of K17 in cell survival and protection from apoptosis53, the regulation of protein synthesis and cell growth during 
wound healing involving K17 in intracellular signaling pathways54, and cell-cycle progression and proliferation 
signaling55, 56.
Downregulation of DKK1 in miR-10b transfected HCEC and organ-cultured corneas along with the down-
regulation of mRNA level of GSK-3β, a Wnt signaling inhibitor, may suggest a role of miR-10b in activating Wnt 
signaling in limbal epithelium. Wnt signaling has been implicated in the maintenance and expansion of adult 
stem cells57–59 as well as of human limbal stem/progenitor cells60. Maintenance of corneal epithelial homeostasis 
depends on the precise regulation of LESC function. LESC have to rapidly respond to different cell conditions 
such as regeneration or tissue damage, proliferate to the exact need and differentiate accordingly to maintain tis-
sue homeostasis. These cellular functions may be regulated by miRNAs, which have the capability of fine-tuning 
gene expression due to their partial base-pairing and adjustability in translational gene regulation in order to 
respond to the needs of the cell at any given time61. Therefore, the miRNA-induced changes in protein levels are 
usually modest61, 62, which may explain weak miR-10b repression of the K17 and DKK1 levels by western blot in 
our study. Alternatively, several miRNAs may fine-regulate gene expression cooperatively.
Our study thus suggests that miR-10b regulates LESC early proliferation state during renewal and/or division 
when cells exit the stem cell niche going through their lateral differentiation to become TA cells. This may involve 
fine-tuned regulation of proliferation to the exact need of the tissue by miR-10b through its downregulation of 
DKK1 and GSK-3β, which leads to upregulation of Wnt signaling24, 57, 60. Further, miR-10b indirectly regulates 
LESC/TA cell K17, which may be through direct targeting of p5363. Eventually, the committed cells differentiate 
while migrating laterally and upward out of the reach of Wnt signaling and under PAX6 and KLF4 regulatory 
mechanisms for terminal differentiation29–31, 40, 42. This is compatible with up-regulation of miR-10 in diabetic 
corneas leading to down-regulation of PAX6 resulting in delayed wound healing, fragility and corneal opacifica-
tion, characteristics of diabetic cornea42.
In summary, we used microRNA deep sequencing in order to advance our understanding of the role of miR-
NAs in normal and diseased corneal states. We identified miRNA expression profiles in human normal and dia-
betic limbus, and found a number of miRNAs that were differentially expressed between normal and both T1DM 
and T2DM corneas. For the first time, we have found a subset of miRNAs that are differentially expressed between 
T1DM vs. T2DM, further suggesting that Type 1 and Type 2 diabetes are different diseases though having the 
same outcome and complications. Physiological significance of this finding warrants further investigation.
The examined miRNAs, especially miR-10b that is one of the most abundant limbal miRNAs, may regulate 
corneal epithelial homeostasis and stem cell functions. They may be considered as excellent candidates for func-
tional studies of limbal progenitor cells in normal and disease states and as possible new tools for treating diabetic 
keratopathy.
Materials and Methods
Human tissues. Age-matched human autopsy normal and diabetic cadaver corneas (Table 1) were received 
from the National Disease Research Interchange (NDRI, Philadelphia, PA) in Optisol storage medium (Chiron 
Vision, Claremont, CA; donor identity was withheld by the supplier. NDRI has a human tissue collection pro-
tocol approved by a managerial committee and subject to National Institutes of Health oversight. In all cases the 
required informed consent from donors’ next of kin specifying the use of postmortem tissue for research was 
obtained by NDRI-affiliated eye banks. The work reported here was covered by approved IRB protocols EX-1055 
and Pro00019393 from Cedars-Sinai Medical Center. Corneas/globes were harvested within 5 hours of donor 
death and reached our laboratory within 24 hours of donor death, and studies were conducted in accordance with 
approved guidelines.
Total RNA isolation. Total RNA including low molecular weight (LMW) RNA was extracted using mir-
Vana miRNA kit (Thermo Fisher Scientific, Waltham, MA) from age-matched normal (n = 10) and DM (n = 12) 
human corneas that were 8.5 mm-trephined into central and limbal components according to the manufacturer’s 
instructions. RNA concentration and quality were assessed using NanoDrop 8000 spectrophotometer (Thermo 
Scientific, Waltham, MA), Qubit 2.0 fluorometer (Invitrogen/Life Technologies, Waltham, MA) and Agilent 2100 
bioanalyzer system (Agilent Technologies, Santa Clara, CA).
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Antigen Antibody Source MW (kDa) Dilution
PAX6 Rabbit pAb 901301 Biolegend 47–50 1:100
KLF4 Rabbit mAb ab151733 Abcam 54 1:50
K17 Mouse mAb sc-58726 Santa Cruz Biotechnology 46 1:100
β-Actin Mouse mAb A5316 Sigma-Aldrich 42 1:6000
β-Actin Rabbit mAb 8457 Cell Signaling Technology 45 1:1000
DKK1 Rabbit mAb ab109416 Abcam 38 1:1000
β-Tubulin Rabbit mAb 2128 Cell Signaling Technology 55 1:1000
Ki-67 Rabbit mAb ab92742 Abcam 359 1:200
Table 2. List of antibodies used in this study. pAb, polyclonal antibody; mAb, monoclonal antibody.
Case 
number Age Gender Cause of death
Type of 
DM
DM duration 
(Years)
History of eye 
diseases
N10-21 79 M Cerebrovascular Accident N/A N/A Cataracts
N10-22 75 F Coronary artery Disease N/A N/A Cataracts
N10-23 75 M Cerebrovascular Accident N/A N/A None
N10-24 66 M Cardiopulmonary Arrest N/A N/A None
N11-11 62 F Congestive Heart Failure N/A N/A None
N11-27 34 F Unknown N/A N/A None
N12-01 82 M Severe Hyponatremia N/A N/A None
N12-03 68 F Intracerebral Hemorrhage N/A N/A None
N12-08 60 M Liver Cancer N/A N/A Cataracts
N12-09 74 F Cancer N/A N/A None
N13-02 57 F Hepatic Encephalopathy N/A N/A None
N13-03 63 F Respiratory Failure N/A N/A None
N13-10 82 F Cardiopulmonary Arrest N/A N/A IOLs OU
N13-45 77 F Respiratory Arrest N/A N/A None
N14-03 91 F Cerebrovascular Accident N/A N/A None
N14-14 80 M Acute Cardiac Event N/A N/A None
N14-37 90 M Respiratory Failure N/A N/A None
N16-33 79 F Respiratory Failure N/A N/A IOLs OU
N16-35 76 F Stroke/CVA N/A N/A None
DM11-18 70 F Cerebrovascular Accident NIDDM 20 None
DM11-30 39 M Renal Disease IDDM Unknown Hematoma behind retina
DM11-31 69 M Renal Failure IDDM Unknown None
DM12-02 74 F Renal Failure NIDDM 10–15 Cataracts OU
DM12-05 51 M Ventricular Fibrillation IDDM Unknown None
DM12-06 56 F Anoxic Encephalopathy NIDDM 15 IOLs OU
DM12-07 46 M Ischemic Heart Disease NIDDM 7 None
DM12-10 74 M Anoxic Encephalopathy NIDDM 15 None
DM12-11 88 M Hypertension NIDDM 20 IOLs OU
DM12-12 60 M CHF IDDM 5 None
DM12-13 81 M Cardiac/Respiratory Arrest IDDM 6 None
DM12-14 80 F Respiratory Failure IDDM 15 None
DM13-01 78 F Pulmonary Disease NIDDM Unknown None
DM13-02 91 M Pneumonia NIDDM 6 IOLs OU
DM13-03 63 F Respiratory Failure IDDM Unknown None
DR13-11 53 F Respiratory Failure IDDM 20 IOLs OU
DM13-13 78 M Respiratory Failure NIDDM 31 None
DM14-12 80 F Stroke IDDM 45 IOLs OU
DM14-50 68 M Respiratory Failure IDDM 28 IOLs OU
Table 1. List of corneas used in this study. N, normal; DM, diabetic mellitus; IDDM, T1DM; NIDDM, T2DM; 
M, male; F, female; IOL, intraocular lens; OU, both eyes.
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Next-Generation miRNA sequencing (miRNA deep sequencing). Sample preparation and sequenc-
ing. One µg of total RNA was used for sequencing library preparation from 10 normal and 12 diabetic corneas 
both central and limbal compartments, a total of 44 samples, with Illumina TruSeq™ Small RNA Library Prep 
kit per the manufacturer’s protocol. In brief, adapters were ligated to both ends of the RNA, transcripts were 
reverse transcribed, and then cDNA was PCR amplified with indexed primers to enable multiplexing samples for 
sequencing. Libraries between 145–160 base pairs long were purified from gel. Libraries were pooled in equimo-
lar concentration for each experiment (8 per lane), and clustered on a single-end flow cell using an Illumina c-bot. 
The library-clustered flow cell was sequenced on the Illumina GAIIx, 1 × 36 bp sequencing chemistry.
Bioinformatics analysis. Quality control and alignments. Fastq files were extracted de-multiplexed using 
Illumina’s Casava V8.1 package. First low-quality reads from the original sequencing data were removed by 
Trim Galore64. Adaptor sequences were removed using a gapped local alignment (Smith-Waterman alignment; 
Match:10, Mismatch: −5, Indel: −8) using a 5 bp match. High quality reads of ~30 bp were retained. Quality reads 
were aligned to human genome GRCH 37 using Bowtie-1 allowing only two mismatches and best stratum align-
ment options. Annotation was obtained from various ncRNA databases and Gencode v19 (human genome) and 
mirBase 20 were used. Exon and intron boundaries were marked and coding regions were excluded. Reads were 
considered to be miRNAs they possessed 100% identity at the sequence level and covered the whole length of the 
miRNA based on the sequences in miRBase. Reads were quantified as sequence tags in each library separately and 
normalized as reads per million (RPM) essentially as advocated in previously published literature65, 66, except that 
we additionally used a local alignment to remove the adaptor sequences.
miRNA filter and differential expression. A miRNA with no read count in all samples were excluded. Further 
miRNAs that showed read count >10 in 75% of samples were retained for further global analysis except that for 
comparison of diabetic vs. normal and T1DM vs. T2DM two group analysis miRNAs showing read counts >10 
reads in all the samples were considered. Differential expression in two groups comparison was calculated using 
one way ANOVA/t-test. A FDR controlled p value was computed using Benjamini and Hochberg procedure for 
multiple hypothesis testing. To further rank differentially expressed miRNAs, the data was shifted to log2 values 
and fold change was calculated.
Quantitative Real-Time RT-PCR (QRT-PCR) and in situ hybridization. QRT-PCR was performed 
as described previously14. Briefly, 10 ng of total RNA were reverse transcribed (RT) using Taqman MicroRNA 
RT kits and miRNA sequence-specific primers (Thermo Fisher Scientific). QPCR was carried out using Taqman 
2X universal PCR Master Mix (no AmpErase UNG) along with Taqman 20X MicroRNA Assays (Thermo Fisher 
Scientific). Each well contained 1.33 µl of RT reaction product, 1X Taqman PCR Master Mix, and 1X specific 
miRNA primer, designed to detect mature miRNAs. Amplification was carried out on the ViiATM 7 Real Time 
PCR System (Thermo Fisher Scientific). Each sample was run in triplicate. Signals were normalized to small 
nucleolar RNA U75 (SNORDU75). U75 housekeeping miRNA run in parallel. A comparative threshold cycle (Ct) 
method (ΔΔCt) was used to calculate relative miRNA expression. High-throughput QRT-PCR on a custom gene 
panel was performed on a Fluidigm BioMark HD system in the Genomic Core at Cedars-Sinai Medical Center 
per manufacture instruction. Primers for miR-10b predicted target and putative LESC and corneal epithelial 
marker genes are listed in Supplementary Table S6. In situ hybridization was performed as described previously12.
Isolation and culture of primary limbal epithelial cells. Primary corneal limbal epithelial cell (LEC) 
cultures were established as described previously14. Briefly, epithelial cells from corneoscleral rims were isolated 
by Dispase/Trypsin digestion and grown in Epilife containing Human Corneal Growth Supplement (HCGS), N-2 
Supplement, B27 Supplement, 1X antibiotic/antimycotic mixture, plus 10 ng/mL epidermal growth factor (EGF) 
(Thermo Fisher Scientific). In addition, primary LEC were maintained in 10 µM Rho-associated protein kinase 
(ROCK) inhibitor (Stemgent, Cambridge, MA) in P0 and removed prior to passage for experiments.
Transfection of human primary limbal epithelial cells and organ-cultured corneas. Human 
Corneal Epithelial Cells (HCECs)12 were transfected with 50 nM hsa-miR-10b-5p mimic (miRCURY LNA™ 
microRNA mimic, Exiqon) or inhibitor (miRCURY LNA™ microRNA inhibitor, Exiqon) or respective negative 
controls using Lipofectamine RNAiMAX transfection reagent (Thermo Fisher Scientific) following the manu-
facturer’s instructions. At Day 3 and 6 post-transfection, cells were either harvested for western blotting, RNA 
isolation or processed for immunocytochemistry or functional assays.
Corneal organ cultures were established as described50 and were maintained in Dulbecco’s Modified Eagle’s 
Medium (Thermo Fisher Scientific) with 1X insulin-transferrin-selenite (Sigma-Aldrich), 1X non-essential 
amino acids, and 1X antibiotic/antimycotic mix (Thermo Fisher Scientific). Each cornea in a pair was trans-
fected with 50 nm hsa-miR-10b mimic or miR-10b inhibitor, with respective negative controls for 48 hours using 
Lipofectamine RNAiMAX transfection reagent. After additional incubation period of 3–5 days, the transfected 
corneas were processed for immunohistochemistry.
In vitro scratch wound assay. HCEC were seeded on coated 12-well plate and transfected with 10b mimic, 
inhibitor or respective controls as described earlier. Transfected HCEC at confluence were scratch wounded using 
the pipette tip and photographed at time 0. The wounds were allowed to heal and photographed every 6 h. All 
images were then analyzed using ImageJ software. The percent area healed was calculated with reference to time 0.
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Cell proliferation (MTS) assay. To assess the effect of miR-10b on proliferation of HCECs, cells were 
seeded on 96-well plate at 5000/well and transfected either with miR-10b mimic, or inhibitor or their respective 
negative controls at final concentration of 50 nM. At the study time points (day 3 and 6 post-transfection), pro-
liferation was measured using MTS assay (CellTiter 96 Aqueous One Solution Cell Proliferation Assay). Briefly, 
20 μl of MTS reagent was added to 100 μl culture media and incubated in cell culture incubator for 4 h. At the end 
of the 4 h incubation, the color change due to reduction of formazan by live proliferating cells was measured with 
a micro-plate reader by absorbance at 490 nM.
Immunostaining. Cultured HCEC or 5-µm thick corneal transverse cryostat sections were fixed in 4% para-
formaldehyde (PFA) and 1% formalin, respectively. Then, cultured cells were permeabilized in 0.2% Triton X-100 
for 10 min at room temperature, then blocked for 1 h in a 2% bovine serum albumin (BSA) in PBS solution. Both 
cultured cells and corneal tissues were incubated with primary antibodies (Table 2) in blocking solution over-
night at 4 °C. It followed the next day by1 hr incubation of cross-species adsorbed secondary antibodies conju-
gated with either fluorescein isothicyanate (FITC) or tetramethylrhodamine (TRITC) (Jackson ImmunoReseach 
Laboratories, West Grove, PA) the dark at room temperature. For each marker the same exposure time was used 
when photographing stained sections. The staining was assessed using six exclusive fields of view for each biolog-
ical replicate for quantitative analysis using ImageJ software. Briefly, images were converted to 8-bit grayscale and 
after background subtraction each image was set to a predetermined threshold for pixel size and then particles 
were analyzed. In order to count smudged cells as individual cells, watershed function was used. At least two inde-
pendent blinded observers performed the analysis using same preset parameters. The pictures are representative 
of two to three independent experiments. Negative controls without a primary antibody were included in each 
experiment.
Western blot analysis. Western blotting was performed as described previously14 with some modifica-
tions. Briefly, 8% to 16% gradient Tris-glycine SDS polyacrylamide gels were used (Thermo Fisher Scientific). 
β-actin (AC-740) or β-tubulin (TUB 2.1) antibodies (Sigma-Aldrich) were used to normalize for gel loading. 
The transferred nitrocellulose membranes were blocked and incubated with primary antibodies for different 
predicted targets/proteins of miR-10b (Table 2). IRDye 800CW or 680RD goat anti-mouse or anti-rabbit (Li-Cor 
Biosciences, Lincoln, NE) was used as secondary antibodies. The blots were scanned using Odyssey CLX imaging 
system (Li-Cor Biosciences).
Statistical analysis. Experiments were analyzed by Student’s t-test for two groups, or ANOVA for three 
or more groups with p < 0.05 considered significant, using Prism6 (GraphPad Software, San Diego, CA). For 
QRT-PCR analysis, the comparative gene expression is normalized with the housekeeping genes. Fold changes 
between two clinical conditions are measured with the ΔΔCt method (2−ΔΔCt). Genes are selected with both fold 
changes and p-values from Student’s t-test.
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